These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 30221497)
1. Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents implantation. Wu Y; Fu X J Clin Lab Anal; 2019 Feb; 33(2):e22666. PubMed ID: 30221497 [TBL] [Abstract][Full Text] [Related]
2. Correlation of pre-operative circulating inflammatory cytokines with restenosis and rapid angiographic stenotic progression risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents. Sun J; Yu H; Liu H; Pu D; Gao J; Jin X; Liu X; Yan A J Clin Lab Anal; 2020 Mar; 34(3):e23108. PubMed ID: 31729103 [TBL] [Abstract][Full Text] [Related]
3. Potential of circulating pro-angiogenic microRNA expressions as biomarkers for rapid angiographic stenotic progression and restenosis risks in coronary artery disease patients underwent percutaneous coronary intervention. Dai R; Liu Y; Zhou Y; Xiong X; Zhou W; Li W; Zhou W; Chen M J Clin Lab Anal; 2020 Jan; 34(1):e23013. PubMed ID: 31495986 [TBL] [Abstract][Full Text] [Related]
4. miR-146a and miR-146b predict increased restenosis and rapid angiographic stenotic progression risk in coronary heart disease patients who underwent percutaneous coronary intervention. Zhang H; Zhang Q; Liu Y; Xue T Ir J Med Sci; 2020 May; 189(2):467-474. PubMed ID: 31680203 [TBL] [Abstract][Full Text] [Related]
5. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI. Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149 [TBL] [Abstract][Full Text] [Related]
6. Occurrence and predictive factors of restenosis in coronary heart disease patients underwent sirolimus-eluting stent implantation. Zhao J; Wang X; Wang H; Zhao Y; Fu X Ir J Med Sci; 2020 Aug; 189(3):907-915. PubMed ID: 31989420 [TBL] [Abstract][Full Text] [Related]
7. Outcomes Among Diabetic Patients Undergoing Percutaneous Coronary Intervention With Contemporary Drug-Eluting Stents: Analysis From the BIONICS Randomized Trial. Konigstein M; Ben-Yehuda O; Smits PC; Love MP; Banai S; Perlman GY; Golomb M; Ozan MO; Liu M; Leon MB; Stone GW; Kandzari DE JACC Cardiovasc Interv; 2018 Dec; 11(24):2467-2476. PubMed ID: 30573057 [TBL] [Abstract][Full Text] [Related]
8. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A; JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416 [TBL] [Abstract][Full Text] [Related]
9. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis. Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768 [TBL] [Abstract][Full Text] [Related]
10. Combining clinical and angiographic variables for estimating risk of target lesion revascularization after drug eluting stent placement. Stolker JM; Cohen DJ; Kennedy KF; Pencina MJ; Arnold SV; Kleiman NS; Spertus JA; Cardiovasc Revasc Med; 2017; 18(3):169-176. PubMed ID: 28041858 [TBL] [Abstract][Full Text] [Related]
11. Levels of plasma Quaking and cyclooxygenase-2 predict in-stent restenosis in patients with coronary artery disease after percutaneous coronary intervention. Wang P; Kuang Y; Liu Y; Zhang Y; Gao H; Ma Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):739-747. PubMed ID: 35837773 [TBL] [Abstract][Full Text] [Related]
12. Association of high level of hs-CRP with in-stent restenosis: A case-control study. Baktashian M; Saffar Soflaei S; Kosari N; Salehi M; Khosravi A; Ahmadinejad M; Moohebati M; Ebrahimi M; Rahmani F; Khameneh-Bagheri R; Ahmadi M; Sadabadi F; Tayefi M; Bazhdanzadeh S; Ferns GA; Hashemi SM; Pasdar A; Ghayour-Mobarhan M Cardiovasc Revasc Med; 2019 Jul; 20(7):583-587. PubMed ID: 30232022 [TBL] [Abstract][Full Text] [Related]
13. Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy. Cheng R; Vanichsarn C; Patel JK; Currier J; Chang DH; Kittleson MM; Makkar R; Kobashigawa JA; Azarbal B Catheter Cardiovasc Interv; 2017 Jul; 90(1):48-55. PubMed ID: 27862865 [TBL] [Abstract][Full Text] [Related]
14. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis. El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402 [TBL] [Abstract][Full Text] [Related]
15. The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era. Zheng C; Kang J; Park KW; Han JK; Yang HM; Kang HJ; Koo BK; Kim HS J Interv Cardiol; 2019; 2019():3270132. PubMed ID: 31772522 [TBL] [Abstract][Full Text] [Related]
16. A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease). Ribichini F; Romano M; Rosiello R; La Vecchia L; Cabianca E; Caramanno G; Milazzo D; Loschiavo P; Rigattieri S; Musarò S; Pironi B; Fiscella A; Amico F; Indolfi C; Spaccarotella C; Bartorelli A; Trabattoni D; Della Rovere F; Rolandi A; Beqaraj F; Belli R; Sangiorgio P; Villani R; Berni A; Sheiban I; Lopera Quijada MJ; Cappi B; Ribaldi L; Vassanelli C; JACC Cardiovasc Interv; 2013 Oct; 6(10):1012-22. PubMed ID: 24055444 [TBL] [Abstract][Full Text] [Related]
17. A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial). Maeng M; Baranauskas A; Christiansen EH; Kaltoft A; Holm NR; Krusell LR; Ravkilde J; Tilsted HH; Thayssen P; Jensen LO Catheter Cardiovasc Interv; 2015 Dec; 86(7):1161-7. PubMed ID: 25640050 [TBL] [Abstract][Full Text] [Related]
18. Serial coronary computed tomography angiography-verified coronary plaque progression: comparison of stented patients with or without diabetes. Shi R; Shi K; Yang ZG; Guo YK; Diao KY; Gao Y; Zhang Y; Huang S Cardiovasc Diabetol; 2019 Sep; 18(1):123. PubMed ID: 31551077 [TBL] [Abstract][Full Text] [Related]
19. Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions. Coroleu SF; De Vita M; Burzotta F; Trani C; Porto I; Niccoli G; Leone AM; Tommasino A; Talarico GP; Schiavoni G; Crea F EuroIntervention; 2012 Oct; 8(6):701-7. PubMed ID: 23086788 [TBL] [Abstract][Full Text] [Related]
20. Relationship between uric acid to albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting. Liu W; Ding K; Bao J; Hu Y; Gui Y; Ye L; Wang L Coron Artery Dis; 2023 Dec; 34(8):589-594. PubMed ID: 37855441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]